Literature DB >> 1772678

Pulmonary hypertensive crises following surgery for congenital heart defects in young children.

R A Hopkins1, C Bull, S G Haworth, M R de Leval, J Stark.   

Abstract

In this clinical study, 20 high risk infants and neonates were monitored to identify and characterize pulmonary hypertensive crises following surgery for congenital cardiac defects. Monitoring included right ventricular or pulmonary artery pressure catheters and transcutaneous oximetry. Eleven patients also had continuous analog recording of hemodynamic data so that antecedents of crises and the sequence of events following treatment could be reconstructed. Eleven of the 20 patients had one or more crises. Six of these ultimately died whereas 5 patients survived with aggressive vasodilator therapy. Four patients without crises but with episodic pulmonary hypertension benefitted from pulmonary vasodilator therapy to ease weaning from ventilatory support. Typically, each crisis was associated with a stress event. Crises were difficult to ablate if not rapidly treated and multiple crises would often cluster following an initial event. High dose narcotic (fentanyl) analgesia was found to be important in the postoperative management. Tolazoline and oxygen were the most consistently useful vasodilators, but isoproterenol and nitrates also played a role. Five of the children who died were examined post mortem: histologically, there was increased pulmonary arterial muscularization in 2, in none were there changes of fixed pulmonary vascular disease. The postoperative management must be individualized on the basis of monitored responses of pulmonary circulation.

Entities:  

Mesh:

Year:  1991        PMID: 1772678     DOI: 10.1016/1010-7940(91)90118-4

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  20 in total

Review 1.  Inhaled nitric oxide and pulmonary vasoreactivity.

Authors:  M Aranda; R G Pearl
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 2.  Review of inhaled nitric oxide in the pediatric cardiac surgery setting.

Authors:  Paul A Checchia; Ronald A Bronicki; Brahm Goldstein
Journal:  Pediatr Cardiol       Date:  2012-04       Impact factor: 1.655

3.  Midterm results of "treat and repair" for adults with non-restrictive ventricular septal defect and severe pulmonary hypertension.

Authors:  Zhenlei Hu; Bo Xie; Xinming Zhai; Jidong Liu; Jianmin Gu; Xudong Wang; Hui Zheng; Song Xue
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

4.  Acute pulmonary hypertension complicating the arterial switch procedure.

Authors:  J Freeman; S Y DeLeon; R H Miles; F X Downey; J Hofstra; J A Quinones; E A Fisher; R Pifarre
Journal:  Pediatr Cardiol       Date:  1995 Nov-Dec       Impact factor: 1.655

5.  Abstracts Nederlandse Werkgroep Hartstimulatie: Lustrum nvt, oktober 2000, Amsterdam.

Authors: 
Journal:  Neth Heart J       Date:  2001-06       Impact factor: 2.380

Review 6.  Treatment of newborn infants with inhaled nitric oxide.

Authors:  R H Mupanemunda; A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

7.  Pulmonary vascular-bronchial interactions: acute reduction in pulmonary blood flow alters lung mechanics.

Authors:  I Schulze-Neick; D J Penny; G P Derrick; R Dhillon; M L Rigby; A Kelleher; A Bush; A N Redington
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

8.  Postoperative use of oral sildenafil in pediatric patients with congenital heart disease.

Authors:  Ju Yeon Uhm; Won-Kyoung Jhang; Jeong-Jun Park; Dong-Man Seo; Sung-Cheol Yun; Tae-Jin Yun
Journal:  Pediatr Cardiol       Date:  2010-01-07       Impact factor: 1.655

9.  Inhaled nitric oxide for pulmonary hypertension after repair of exomphalos.

Authors:  O I Miller; J W Gaynor; D J Macrae; R C Tasker
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

10.  Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease.

Authors:  P Winberg; B P Lundell; L E Gustafsson
Journal:  Br Heart J       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.